- $1.59bn
- $2.72bn
- $3.96bn
- 77
- 86
- 85
- 96
Annual income statement for V2X, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,383 | 1,396 | 1,784 | 2,891 | 3,963 |
Cost of Revenue | |||||
Gross Profit | 128 | 124 | 160 | 295 | 335 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1,333 | 1,352 | 1,722 | 2,835 | 3,861 |
Operating Profit | 49.6 | 43.5 | 62 | 55.8 | 102 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 43.2 | 38.7 | 54 | -6.11 | -24.5 |
Provision for Income Taxes | |||||
Net Income After Taxes | 33.2 | 37 | 45.7 | -14.3 | -22.6 |
Net Income Before Extraordinary Items | |||||
Net Income | 33.2 | 37 | 45.7 | -14.3 | -22.6 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 33.2 | 37 | 45.7 | -14.3 | -22.6 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 5.84 | 12.7 | 3.86 | 0.553 | -0.26 |